Yujing Wang

TL;DR: Microneedle‐based transdermal and ocular drug delivery systems have the potential to greatly impact not only patient benefits, but also industry, and through diligence, innovation and collaboration, their true potential will begin to be realised within the next 3–5 years.

TL;DR: The challenges and opportunities of posterior segment drug delivery via the periocular route are highlighted, and the importance of understanding complex barrier functions so as to continue to develop innovative drug-delivery systems is envisaged.

TL;DR: In this article, a model protein, ovalbumin (OVA)-encapsulated PLGA NPs were prepared and optimized using a water-in-oil-inwater (W/O/W) double emulsion method.

TL;DR: This work provides a useful approach for the fabrication of drug-eluting beads used in transarterial chemoembolization by providing in vitro cytotoxicity experiments and classical matrigel endothelial tube assay certificated the maintaining bioactivity of cisplatin and sorafenib tosylate released from the microspheres, respectively.

TL;DR: This study demonstrates the applicability of biodegradable poly(D,L-lactic acid) microspheres loaded with cisplatin and sorafenib tosylate for local drug delivery as well as the potential of thesemicrospheres for future use in transarterial chemoembolization.